TRANSFORMATION OF LYMPHOCYTE-T SUBSETS BY MAREKS-DISEASE HERPESVIRUS

被引:121
|
作者
SCHAT, KA [1 ]
CHEN, CLH [1 ]
CALNEK, BW [1 ]
CHAR, D [1 ]
机构
[1] UNIV ALABAMA, CTR COMPREHENS CANC, DEPT MICROBIOL, BIRMINGHAM, AL 35294 USA
关键词
D O I
10.1128/JVI.65.3.1408-1413.1991
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Marek's disease herpesvirus (MDV)-transformed lymphoblastoid tumor cell lines were characterized for the presence of the surface markers. Monoclonal antibodies were used for CD3 (T-cell receptor [TCR] complex), TCR1, TCR2, and TCR3, CD4, CD8, and Ia antigen by indirect fluorescence staining followed by microscopic examination or flow cytometry. The lymphoblastoid cell lines were obtained from tumors from chickens infected with MDV (n = 44) or from local lesions induced by inoculation of allogeneic, MDV-infected chick kidney cells (n = 56). Lymphocytes were harvested from these lesions between 4 and 16 days postinoculation and cultured in vitro to establish cell lines. All cell lines expressed Ia antigen and CD3 and/or TCR and thus are activated T cells. Most of the cell lines developed from tumors were CD4+ CD8-; only one cell line was negative for both markers. Sixteen percent of the cell lines were TCR3+, while the remainder were TCR2+. The cell lines developed from local lesions were much more heterogeneous: 45% were CD4- CD8+, 34% were CD4- CD8-, and only 21% were CD4+ CD8-. The number of TCR3+ cell lines was larger than expected for the CD4- CD8+ and CD4- CD8- cell lines, as judged from the presence of these cells in the blood. These results indicate that several subsets of T lymphocytes can be transformed by MDV, depending on the pathogenesis of infection. Activation of T cells as a consequence of the normal pathogenesis or by allogeneic stimulation seem to be a first important step in the process of transformation.
引用
收藏
页码:1408 / 1413
页数:6
相关论文
共 50 条
  • [1] MAREKS-DISEASE VIRUS AND HERPESVIRUS OF TURKEYS
    PURCHASE, HG
    [J]. PROGRESS IN MEDICAL VIROLOGY, 1974, 18 : 178 - 197
  • [2] MAREKS-DISEASE - A MODEL FOR HERPESVIRUS ONCOLOGY
    CALNEK, BW
    [J]. CRC CRITICAL REVIEWS IN MICROBIOLOGY, 1986, 12 (04): : 293 - 320
  • [3] LYMPHOCYTE-T SUBSETS IN CASTLEMANS DISEASE
    FRANCO, V
    ARAGONA, F
    GENOVA, G
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 1987, 182 (04) : 490 - 490
  • [4] EFFECTS OF HERPESVIRUS CARRIER STATUS ON PERIPHERAL LYMPHOCYTE-T SUBSETS
    GRATAMA, JW
    NAIPAL, AMIH
    OOSTERVEER, MAP
    STIJNEN, T
    KLUINNELEMANS, HC
    GINSEL, LA
    DENOTTOLANDER, GJ
    HEKKER, AC
    DAMARO, J
    VANDERGIESSEN, M
    TANKE, HJ
    [J]. BLOOD, 1987, 70 (02) : 516 - 523
  • [5] MAREKS-DISEASE HERPESVIRUSES .4. MOLECULAR CHARACTERIZATION OF MAREKS-DISEASE HERPESVIRUS-A ANTIGEN
    GLAUBIGER, C
    NAZERIAN, K
    VELICER, LF
    [J]. JOURNAL OF VIROLOGY, 1983, 45 (03) : 1228 - 1234
  • [6] VACCINATION AGAINST MAREKS-DISEASE WITH AUSTRALIAN STRAINS OF TURKEY HERPESVIRUSES AND AN ATTENUATED MAREKS-DISEASE HERPESVIRUS
    MUSTAFFABABJEE, A
    SPRADBROW, PB
    [J]. AUSTRALIAN VETERINARY JOURNAL, 1973, 49 (07) : 347 - 353
  • [7] RESPONSE OF EMBRYOS TO LYMPHOMATOUS HERPESVIRUS OF MAREKS-DISEASE
    LONGENEC.BM
    PAZDERKA, F
    STONE, H
    RUTH, RF
    [J]. FEDERATION PROCEEDINGS, 1974, 33 (03) : 739 - 739
  • [8] LYMPHOCYTE-T SUBSETS AND ANTIGEN RECOGNITION BY LYMPHOCYTE-T
    BRACIALE, TJ
    [J]. ANIMAL GENETICS, 1988, 19 : 69 - 72
  • [9] LYMPHOCYTE-T SUBSETS IN BEHCETS-DISEASE
    KANSU, E
    UNAL, S
    KARACADAG, S
    BATMAN, F
    TELATAR, H
    ZILELI, T
    DUNDAR, S
    [J]. CLINICAL RESEARCH, 1985, 33 (02): : A299 - A299
  • [10] MAREKS-DISEASE HERPESVIRUSES .2. PURIFICATION AND FURTHER CHARACTERIZATION OF MAREKS-DISEASE HERPESVIRUS-A ANTIGEN
    LONG, PA
    CLARK, JL
    VELICER, LF
    [J]. JOURNAL OF VIROLOGY, 1975, 15 (05) : 1192 - 1201